Patent · US Active

Method for obtaining globally activated monocytes

US12364755B2 · kind B2 · utility

0Cited by

8References

13Claims

0Family size

Assignees

Transimmune AG · DE
Yale University · US

Inventors

Gunter Bauer · Sulzbach-Rosenberg, DE
Justin DUCKWORTH · Mickleham, GB
Robert TIGELAAR · New Haven, US
Richard L. Edelson · Westport, US
Michael Girardi · Overland Park, US
Karsten Henco · Erkrath, DE
Adrian Hayday · Ashford, GB

Key dates

Filing date	Nov 18, 2021
Grant date	Jul 22, 2025
Priority date	—
Expiry date	Jan 23, 2043

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12N2521/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to methods for producing immuno-stimulatory autologous dendritic cells. The present invention further relates to the use of such cells for treating patients suffering from hyper-proliferative disease such as cancer.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.